Although we found the GTS-21 and PNU did not contribute significantly in reducing inflammation and improving behavior, there were some limitations to our current study and notable findings that suggest that treating SLE mice at an earlier stage with potent α7 ligands could be beneficial. The gene discussed is IGKV2D-24; the disease is systemic lupus erythematosus.